Exhibit 99.1

JOINT FILING AGREEMENT
 
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of Seelos Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
 
February 14, 2025
 
LIND GLOBAL FUND II LP
   
By:
 
Lind Global Partners II LLC
 
 
its General Partner
   
By:
  
/s/ Jeff Easton
Name:
 
Jeff Easton
Title:
 
Managing Member
 
LIND GLOBAL PARTNERS II LLC
   
By:
 
/s/ Jeff Easton
Name:
 
Jeff Easton
Title:
 
Managing Member
     
LIND GLOBAL ASSET MANAGEMENT V, LLC
     
By:
  
/s/ Jeff Easton
Name:
  
Jeff Easton
Title:
  
Managing Member
 
JEFF EASTON
 
By:
 
/s/ Jeff Easton

Seelos Therapeutics (CE) (USOTC:SEELQ)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025 Plus de graphiques de la Bourse Seelos Therapeutics (CE)
Seelos Therapeutics (CE) (USOTC:SEELQ)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025 Plus de graphiques de la Bourse Seelos Therapeutics (CE)